만성신장질환의 동반질환이 말기신부전으로의 진행에 미치는 영향
Effects for Comorbidities of Chronic Kidney Disease on the Progression to End-stage Renal Disease
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Objectives: Due to the aging of population and increase of chronic diseases worldwide, the prevalence of chronic kidney disease (CKD) is on the rise. The increase of CKD is connected to the development of end-stage renal diseases (ESRD) and the occurrence of death caused by ESRD. This study explored the risk factors affecting the progression of CKD patients to ESRD using the sample cohort database built by the Korean National Health Insurance Service. Methods: This study targeted 2,354 new patients to whom the CKD occurred between 2003 and 2012. The development of ESRD of the CKD patients was checked through the number of cases per 1,000 person years. Significance was confirmed through the t-test and Wilcoxon signed-rank test. For the factors affecting the occurrence of ESRD by risk factor of comorbidities, the Cox proportional hazard regression analysis was carried out. Results: The average routing period of the subjects of this study was 2.98 ± 2.69 years. 105.69 cases of ESRD among CKD patients took place per 1,000 person years during the observation period. The proportional hazard of CKD patients’ ESRD became higher as the subjects’ age became younger (50-59, HR = 0.76; 60-69, 0.64; 70-79, HR = 0.63), and the proportional hazard was higher from the subjects having proteinuria (Yes, HR = 2.16), high hypertension (Yes, HR = 1.38), diabetes mellitus (Yes, HR = 1.23), and anemia (Yes, HR = 1.77) (All p< 0.05). Conclusions: Risk factors for the progression of CKD to ESRD were low age group (less than 60), underweight (less than 23), diabetes, hypertension, and anemia patients. To control the occurrence of ESRD that increases social and economic burdens, along with death risk, it is necessary to establish individualized treatment plans depending on the characteristics and risks of patients based on each type of comorbidity.
Abstract
Objectives: Due to the aging of population and increase of chronic diseases worldwide, the prevalence of chronic kidney disease (CKD) is on the rise. The increase of CKD is connected to the development of end-stage renal diseases (ESRD) and the occurrence of death caused by ESRD. This study explored the risk factors affecting the progression of CKD patients to ESRD using the sample cohort database built by the Korean National Health Insurance Service. Methods: This study targeted 2,354 new patients to whom the CKD occurred between 2003 and 2012. The development of ESRD of the CKD patients was checked through the number of cases per 1,000 person years. Significance was confirmed through the t-test and Wilcoxon signed-rank test. For the factors affecting the occurrence of ESRD by risk factor of comorbidities, the Cox proportional hazard regression analysis was carried out. Results: The average routing period of the subjects of this study was 2.98 ± 2.69 years. 105.69 cases of ESRD among CKD patients took place per 1,000 person years during the observation period. The proportional hazard of CKD patients’ ESRD became higher as the subjects’ age became younger (50-59, HR = 0.76; 60-69, 0.64; 70-79, HR = 0.63), and the proportional hazard was higher from the subjects having proteinuria (Yes, HR = 2.16), high hypertension (Yes, HR = 1.38), diabetes mellitus (Yes, HR = 1.23), and anemia (Yes, HR = 1.77) (All p< 0.05). Conclusions: Risk factors for the progression of CKD to ESRD were low age group (less than 60), underweight (less than 23), diabetes, hypertension, and anemia patients. To control the occurrence of ESRD that increases social and economic burdens, along with death risk, it is necessary to establish individualized treatment plans depending on the characteristics and risks of patients based on each type of comorbidity.
참고문헌 (34)
- GBD Chronic Kidney Disease Collaboration, "Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017", Lancet, 395, pp.709~733 (2020)[DOI]
- 진호준, "노인 말기신부전 환자의 치료결정", 대한내과학회지, 85(1), pp.29~32 (2013), 대한내과학회[DOI]
- "Korea National Health and Nutrition Examination Survey. 2018 National health statistics"[URL]
- "National Health Information Portal, End-Stage Renal Disease; ESRD"[URL]
- 차지은, "장기 혈액투석환자의 신체적, 심리적, 사회적 요인이 질병 부담감에 미치는 영향", 보건정보통계학회지, 43(3), pp.159~166 (2018), 한국보건정보통계학회[DOI]
- Yang CW, "Current status and future in patients with end stage renal disease in Korea", J Korean Med Assoc, 56(7), pp.560~561 (2013)[DOI]
- "Current renal replacement therapy in Korea. Current status of Korean renal replacement therapy in 2018"[URL]
- 진동찬, "Current characteristics of dialysis therapy in Korea: 2015 registry data focusing on elderly patients", Kidney Research and Clinical Practice, 35(4), pp.204~211 (2016), 대한신장학회
- 김대중, "우리나라 당뇨병성 말기 신부전증의 현황: 건강보험자료 분석결과", Diabetes and Metabolism Journal, 30(5), pp.355~362 (2006), 대한당뇨병학회
- 손영기, "당뇨병성 말기 신부전 환자에서 시행한 신장이식의 단일센터 임상성적", 대한내과학회지, 77(3), pp.321~327 (2009), 대한내과학회
- A 10-year longitudinal study on the patient survival and renal survival by specific causes of the chronic kidney diseases, "Ahn C", Seoul National University Hospital, Korea Disease Control and Prevention, ~ (2016)
- Analysis of thyroid cancer trends and influencing factors using national health insurance data, "Lim CY", NHIS Ilsan Hospital Instutute of Health Insurance and Clinical Research, ~ (2015)
- 서화정, "Care Pathway for Cancer Survivorship in Korea: Trend of Breast Cancer Pathway from 2003 to 2010", Healthcare Informatics Research, 23(2), pp.119~125 (2017), 대한의료정보학회[DOI]
- Seon-Ha Kim, "Economic burden of chronic kidney disease in Korea using national sample cohort", Journal of Nephrology, 30(6), pp.787~793 (2017), Springer Science and Business Media LLC[DOI]
- 김경민, "Impact of chronic kidney disease on mortality: A nationwide cohort study", Kidney Research and Clinical Practice, 38(3), pp.382~390 (2019), 대한신장학회[DOI]
- Choi HS, "Smoking and risk of incident end-stage kidney disease in general population : a nationwide population-based cohort study from Korea", Sci Rep, 9(1), pp.19511~ (2019)[DOI]
- Quan H, "Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data", Med Care, 43(11), pp.1130~1139 (2005)[DOI]
- "Health Insurance Review and Assessment Service 2016 Health insurance statistical yearbook"[URL]
- Grams ME, "Risks of adverse events in advanced CKD: the chronic renal insufficiency cohort (CRIC) study", Am J Kidney Dis, 70(3), pp.337~346 (2017)[DOI]
- Tonelli M, "A population-based cohort study defines prognoses in severe chronic kidney disease", Kidney Int, 93(5), pp.1217~1226 (2018)[DOI]
- Kim YH, "Underweight increases the risk of end-stage renal diseases for type 2 diabetes in Korean population : data from the National Health Insurance Service Health Checkups 2009-2017", Diabetes Care, 43(5), pp.1118~1125 (2020)[DOI]
- Caravaca F, "Obesity and mortality in advanced chronic renal failure patients", Nefrologia, 24(5), pp.453~462 (2004)
- 윤영숙, "비만과 만성 신장 질환", Journal of Obesity & Metabolic Syndrome, 18(4), pp.123~130 (2009), 대한비만학회
- Currie CJ, "Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status", PLoS One, 14(8), pp.e0221044~ (2019)[DOI]
- Lai CC, "The association between COPD and outcomes of patients with advanced chronic kidney disease", Int J Chron Obstruct Pulmon Dis, 13, pp.2899~2905 (2018)[DOI]
- Li Y, "Impact of achieved blood pressure on renal function declineand first stroke in hypertensive patients with chronic kidney disease", Nephrol Dial Transplant, 33(3), pp.409~417 (2018)[DOI]
- Nishimura RA, "2017 AHA", ACC focused update of the 2014 AHA, American Heart Association Task Force on Clinical Practice Guidelines, pp.Circulation, 2017[DOI]
- "Comprehensive disease information"[URL]
- 류상열, "The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)", Journal of Korean Medical Science, 32(2), pp.249~256 (2017), 대한의학회
- Stauffer ME, "Prevalence of anemia in chronic kidney disease in the United States", PLoS One, 9, pp.e84943~ (2014)[DOI]
- Toft G, "Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease : a Danish population-based study", J Nephrol, 33(1), pp.147~156 (2020)[DOI]
- "Kidney disease information for the public"[URL]
- National Kidney Foundation, "KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease", Kidney Int Suppl, 3(1), pp.1~150 (2013)
- "Standards for health examination"[URL]